← 返回

IL21 主要由一个与 CXCL13 相关的 CD4(+) T 细胞亚群产生,并塑造结直肠癌的免疫微环境

英文原题:IL21 is predominantly produced by a CXCL13 associated CD4(+) T cell subset and shapes the immune microenvironment in colorectal cancer.

查看英文原题

IL21 is predominantly produced by a CXCL13 associated CD4(+) T cell subset and shapes the immune microenvironment in colorectal cancer.

PubMed 2026/06/26(内容时间) Front Immunol Q1 · IF 7(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

研究概要

我们的研究确定了 CXCL13 相关 CD4+ T 细胞是结直肠癌中产生 IL21 的主要细胞群体,并将这一轴与免疫活跃的肿瘤微环境联系起来。尽管直接的机制验证仍是必要的,但我们的发现为未来研究 IL21 介导的结直肠癌免疫调控提供了细胞和转录框架。

研究思路结论见上方概要

白细胞介素-21(IL21)是参与抗肿瘤免疫应答的重要免疫调节细胞因子;然而,其在结直肠癌中的细胞来源、调控程序及功能意义仍未完全阐明。

我们分析了来自公共单细胞RNA测序数据集的肿瘤浸润T细胞,以表征结直肠癌中IL21的表达模式。使用接受抗PD-1新辅助治疗的结直肠癌细胞的单细胞队列进行了外部验证。对结直肠癌组织微阵列进行多重免疫荧光染色,以验证IL21的空间分布和细胞来源。相关性分析用于评估IL21与免疫相关细胞亚群之间的关系。进行SCENIC分析以识别与CXCL13相关CD4 + T细胞亚群相关的候选转录因子。此外,将AOM/DSS诱导的小鼠结直肠癌模型的肿瘤组织在体外培养(有或无IL21),并进行批量RNA测序,以探索IL21诱导的转录变化。

单细胞分析显示,IL21 的表达局限于一小部分肿瘤浸润 T 细胞,并且主要富集于 CD4 + T 细胞亚群,尤其是 CXCL13 + CD4 + T 细胞群体,而 IL21R 的表达则更为广泛。对 PD-1 抗新辅助治疗队列的分析进一步证实,IL21 也优先表达于特化的 CD4 + T 细胞亚群,包括与 CXCL13 相关的细胞群体。组织水平多重免疫荧光证实,与癌旁正常组织相比,肿瘤组织中 IL21、IL21 + CD4 + T 细胞以及 CXCL13 + IL21 + CD4 + T 细胞均显著增加。相关性分析进一步提示,IL21 表达与 CD4 +、CXCL13 +、IL21 + CD4 + 以及 CXCL13 + IL21 + CD4 + T 细胞群体呈正相关。SCENIC 分析在 CD4_C09-CXCL13 亚群中鉴定出独特的调控子图谱,其中 STAT1、IRF9、IRF7、TBX21 和 IRF4 成为候选关键转录因子。在功能上,外源性 IL21 在小鼠结直肠肿瘤组织中诱导了显著的转录重塑,其特征为免疫和细胞因子相关通路的激活以及多个 Wnt 相关基因的抑制。

展开英文摘要原文

Interleukin-21 (IL21) is an important immunoregulatory cytokine involved in antitumor immune response; however, its cellular source, regulatory program, and functional significance in colorectal cancer remain incompletely understood.

We analyzed tumor-infiltrating T cells from the public single-cell RNA sequencing dataset to characterize IL21 expression patterns in colorectal cancer. External validation was performed using a single-cell cohort of colorectal cancer cells treated with anti-PD-1 neoadjuvant therapy. Multiplex immunofluorescence staining was performed on colorectal cancer tissue microarrays to validate the spatial distribution and cellular origin of IL21. Correlation analysis was used to assess the relationship between IL21 and immune-related cell subsets. SCENIC analysis was performed to identify candidate transcription factors associated with CXCL13-associated CD4 + T cell subsets. Furthermore, tumor tissues from an AOM/DSS-induced mouse colorectal cancer model were cultured in vitro (with or without IL21) and batch RNA sequenced to explore IL21-induced transcriptional changes.

Single-cell analysis showed that IL21 expression was restricted to a limited fraction of tumor-infiltrating T cells and was predominantly enriched in CD4 + T cell subsets, particularly CXCL13 + CD4 + T cell populations, whereas IL21R was more broadly expressed. Analysis of the PD-1 anti-neoadjuvant therapy cohort further confirmed that IL21 is also preferentially expressed in specialized CD4 + T cell subsets, including CXCL13-associated cell populations. Tissue-level multiplex immunofluorescence confirmed that IL21, IL21 + CD4 + T cells, and CXCL13 + IL21 + CD4 + T cells were all significantly increased in tumor tissues compared with adjacent normal tissues. Correlation analysis further suggested that IL21 expression was positively associated with CD4 + , CXCL13 + , IL21 + CD4 + , and CXCL13 + IL21 + CD4 + T cell populations. SCENIC analysis identified a distinct regulon landscape in the CD4_C09-CXCL13 subset, with STAT1, IRF9, IRF7, TBX21, and IRF4 emerging as candidate key transcription factors. Functionally, exogenous IL21 induced marked transcriptional remodeling in murine colorectal tumor tissues, characterized by activation of immune- and cytokine-related pathways and suppression of multiple Wnt-associated genes.

Our study identifies CXCL13-associated CD4 + T cells as a major IL21-producing population in colorectal cancer and links this axis to an immune-active tumor microenvironment. Although direct mechanistic validation remains necessary, our findings provide a cellular and transcriptional framework for future investigation of IL21-mediated immune regulation in colorectal cancer.

论文信息

作者
Lu P、Zhou H、Jiang H、Wu Y、Yang H、Liu Y、Wu S、Yang M
单位
Department of Nephrology, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu, China.China
期刊
Frontiers in immunology2026
原文标识
PubMed 42433376 · DOI 10.3389/fimmu.2026.1865519